HC Wainwright & Co. initiated coverage on Kintara Therapeutics with a new price target
$KTRA
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. initiated coverage of Kintara Therapeutics with a rating of Buy and set a new price target of $6.00